Thirty-year experience with a bileaflet mechanical valve prosthesis

Slides:

Advertisements

Similar presentations

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P

Advertisements

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Of mice and men and surgical transcatheter aortic valve insertion

Twenty-Five Year Experience With the St

Clinical event rates with the On-X bileaflet mechanical heart valve: A multicenter experience with follow-up to 12 years John B. Chambers, MD, FRCP,

Clinical experience with the carbomedics valve: Early results with a new bileaflet mechanical prosthesis J.Francisco Nistal, MD, Aquilino Hurlé, MD,

Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: A prospective multicenter study Vincent Chan,

Reoperative aortic valve replacement in the octogenarians—minimally invasive technique in the era of transcatheter valve replacement Tsuyoshi Kaneko,

Sergey Leontyev, MD, Michael A

Management of concomitant mild to moderate functional mitral regurgitation during aortic valve surgery for severe aortic insufficiency Ju Yong Lim, MD,

In which patients is transcatheter aortic valve replacement potentially better indicated than surgery for redo aortic valve disease? Long-term results.

Long-term prognosis of ascending aortic aneurysm after aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis Evaldas Girdauskas,

Prospective randomized comparison of CarboMedics and St

Bigger valve size is not always better

A 10-Year Experience With the Carbomedics Cardiac Prosthesis

Anticoagulation in Children With Mechanical Valve Prostheses

Eleven-Year Single-Center Experience with the ATS Open Pivot Bileaflet Heart Valve Doan Baykut, MD, Leticia Grize, PhD, Christian Schindler, PhD, Angelika.

W. R. Eric Jamieson, MD, Guy J. Fradet, MD, James G

Advancing the science of myocardial recovery with mechanical circulatory support: A Working Group of the National, Heart, Lung, and Blood Institute Stavros.

Form ever follows function

Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery Vincent Chan, MD, MPH, Thierry.

Early degeneration of the St Jude Medical Trifecta bioprosthetic aortic valve: A problem of the leaflets or of the stent? Giuseppe Santarpino, MD, Steffen.

Scott A. Hittinger, MD, Tom P. Theruvath, MD, PhD, John S

Bicuspid aortic valve aortopathy: One size fits all?

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

Outcome after surgery for prosthetic valve endocarditis and the impact of preoperative treatment Herko Grubitzsch, MD, PhD, Andreas Schaefer, Christoph.

The variability of the mitral valve anatomy and terminology

Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.

Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement Vincent Chan, MD, MPH, B-Khanh Lam, MD, MPH,

Outcomes after mechanical aortic valve replacement in children and young adults with congenital heart disease Patrick O. Myers, MD, Suyog A. Mokashi,

Quality of mitral valve surgery at the United States Department of Veterans Affairs Juan A. Crestanello, MD The Journal of Thoracic and Cardiovascular.

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P

Innovation and science: The future of valve design

Structural deterioration of the Freestyle aortic valve: Mode of presentation and mechanisms Siamak Mohammadi, MD, Richard Baillot, MD, Pierre Voisine,

Aortic valve replacement with the Mitroflow pericardial bioprosthesis: Durability results up to 21 years Charles A. Yankah, MD, PhD, Miralem Pasic, MD,

Military surgeons just want to have fun

Stentless biological valved conduit for aortic root replacement: Initial experience with the Shelhigh BioConduit model NR-2000C Abdullah Kaya, MD, Robin.

Twenty-year experience with the St Jude Medical mechanical valve prosthesis John S Ikonomidis, MD, PhD, John M Kratz, MD, Arthur J Crumbley, MD, Martha.

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Up to 8-year follow-up of valve replacement with CarboMedics valve

Fifteen years of experience with ATS mechanical heart valve prostheses

Robert W. Emery, MD, Christopher C. Krogh, Kit V. Arom, MD, PhD, Ann M

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Tirone E. David, MD, Gheorghe Gavra, MD, Christopher M

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Replicating the success of mitral valve repair in the aortic valve

Bradley G. Leshnower, MD, Robert A. Guyton, MD, Richard J

Manuel J. Antunes, MD, PhD, DSc

St Jude Medical Regent valve

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

The Mitroflow aortic valve: A past, present, and future illuminated

Warfarin or aspirin after mitral valve repair: Why work harder?

Hans-Joachim Schäfers, MD

Arnt E Fiane, MD, Odd R Geiran, MD, PhD, Jan L Svennevig, MD, PhD

Concomitant replacement of the ascending aorta is free—for some

First nights, the adrenal axis, and steroids

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Keep it short and sweet Ian A. Makey, MD, Scott B. Johnson, MD

Severe tricuspid or mitral regurgitation in inoperable patients with aortic stenosis. Can we leave them alone? Juan A. Crestanello, MD The Journal of.

The future of cardiac surgery training: A survival guide

Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable Craig M. Jarrett,

Another case of underprovision of mitral valve repair surgery: Lessons from the Veterans Affairs health system Anelechi C. Anyanwu, MD, David H. Adams,

The CarboMedics Valve: Experience With 1,049 Implants

Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD

Clinical event rates with the On-X bileaflet mechanical heart valve: A multicenter experience with follow-up to 12 years John B. Chambers, MD, FRCP,

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? F. Dagenais, MD, P. Cartier, MD, P. Voisine,

Thanos Sioris, MD, Tirone E

Presentation transcript:

Thirty-year experience with a bileaflet mechanical valve prosthesis Scott Johnson, MD, Martha R. Stroud, MS, John M. Kratz, MD, Scott M. Bradley, MD, Fred A. Crawford, MD, John S. Ikonomidis, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 157, Issue 1, Pages 213-222 (January 2019) DOI: 10.1016/j.jtcvs.2018.09.002 Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Actuarial survival after AVR and MVR. AVR, Aortic valve replacement; MVR, mitral valve replacement. The Journal of Thoracic and Cardiovascular Surgery 2019 157, 213-222DOI: (10.1016/j.jtcvs.2018.09.002) Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Actuarial and “actual” freedom from reoperation after AVR and MVR. AVR, Aortic valve replacement; MVR, mitral valve replacement. The Journal of Thoracic and Cardiovascular Surgery 2019 157, 213-222DOI: (10.1016/j.jtcvs.2018.09.002) Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Actuarial and “actual” freedom from thromboembolic events after AVR and MVR. AVR, Aortic valve replacement; MVR, mitral valve replacement. The Journal of Thoracic and Cardiovascular Surgery 2019 157, 213-222DOI: (10.1016/j.jtcvs.2018.09.002) Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Actuarial and “actual” freedom from valve thrombosis after AVR and MVR. AVR, Aortic valve replacement; MVR, mitral valve replacement. The Journal of Thoracic and Cardiovascular Surgery 2019 157, 213-222DOI: (10.1016/j.jtcvs.2018.09.002) Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 Actuarial and “actual” freedom from bleeding events after AVR and MVR. AVR, Aortic valve replacement; MVR, mitral valve replacement. The Journal of Thoracic and Cardiovascular Surgery 2019 157, 213-222DOI: (10.1016/j.jtcvs.2018.09.002) Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

Figure 6 Actuarial and “actual” freedom from PVE after AVR and MVR. PVE, Prosthetic valve endocarditis; AVR, aortic valve replacement; MVR, mitral valve replacement. The Journal of Thoracic and Cardiovascular Surgery 2019 157, 213-222DOI: (10.1016/j.jtcvs.2018.09.002) Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

Figure 7 Actuarial and “actual” freedom from valve-related morbidity or mortality after AVR and MVR. The Journal of Thoracic and Cardiovascular Surgery 2019 157, 213-222DOI: (10.1016/j.jtcvs.2018.09.002) Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions

Valve-related mortality and mortality/morbidity for the St Jude Medical (Saint Paul, Minn) prosthesis. The Journal of Thoracic and Cardiovascular Surgery 2019 157, 213-222DOI: (10.1016/j.jtcvs.2018.09.002) Copyright © 2018 The American Association for Thoracic Surgery Terms and Conditions